Prostate cancer cells home to bone using a novel in vivo model : modulation by the integrin antagonist GLPG 0187 Running title : new in vivo model for tracking early prostate cancer homing to bone

Urology Research Laboratory 3 , Department of Urology, University of Bern, Murtenstrasse 35, CH3010, Bern, Switzerland Department of Urology 4 , Leiden University Medical Center, J3-100, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Urology & Oncology 5 , Nuffield Department of Surgery, John Radcliffe Hospital University of Oxford, Oxford, OX3 9DU, UK Galapagos SASU 6 , 60, Avenue Gaston Roussel, 93230 Romainville, France

[1]  S. Cross,et al.  The angiogenic switch occurs at the adenoma stage of the adenoma–carcinoma sequence in colorectal cancer , 2007, Gut.

[2]  N. Clarke,et al.  bone marrow endothelium: binding , 2022 .

[3]  K. Pienta,et al.  An in vivo mouse model for human prostate cancer metastasis. , 2008, Neoplasia.

[4]  O. Rokhlin,et al.  Expression of cellular adhesion molecules on human prostate tumor cell lines , 1995, The Prostate.

[5]  J. Rhim,et al.  Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia cell lines. Influence of IL-10, follistatin, activin-A, and DHT. , 1999, International Journal of Oncology.

[6]  L. Chung,et al.  Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. , 1994, Cancer research.

[7]  A. Gown,et al.  Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. , 2008, Cancer research.

[8]  M. Reed,et al.  Evaluation of Fluorescent Plasma Markers for in vivo Microscopy of the Microcirculation , 2012, Journal of Vascular Research.

[9]  Balázs Sarkadi,et al.  The role of ABC transporters in drug resistance, metabolism and toxicity. , 2004, Current drug delivery.

[10]  G. Risbridger,et al.  An in vivo model of prostate carcinoma growth and invasion in bone , 2002, Cell and Tissue Research.

[11]  N. Clarke,et al.  Molecular mechanisms of metastasis in prostate cancer. , 2009, Asian journal of andrology.

[12]  R. Luksch,et al.  Expression of integrins in human bone marrow , 1990, British journal of haematology.

[13]  S. Cross,et al.  Microvascular Endothelial Cell Responses in vitro and in vivo: Modulation by Zoledronic Acid and Paclitaxel? , 2010, Journal of Vascular Research.

[14]  S. Kukreja,et al.  Patterns of metastasis by the human prostate cancer cell line PC‐3 in athymic nude mice , 1989, The Prostate.

[15]  Ivo Que,et al.  Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. , 2002, The American journal of pathology.

[16]  K. Messmer,et al.  Dorsal skinfold chamber technique for intravital microscopy in nude mice. , 1993, The American journal of pathology.

[17]  M. Hung,et al.  Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  G. van der Pluijm,et al.  Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer. , 2011, The American journal of pathology.

[19]  G. Jayson,et al.  Alpha-v Integrins as Therapeutic Targets in Oncology , 2007, Cancer investigation.

[20]  S. Jacobs.  Spread of prostatic cancer to bone. , 1983, Urology.

[21]  Joe W Gray,et al.  Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. , 2006, Cancer research.

[22]  K. Honn,et al.  Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix , 1992, Cancer and Metastasis Reviews.

[23]  R. Ganz,et al.  Potential role of pre-existing blood vessels for vascularization and mineralization of osteochondral graftsAn intravital microscopic study in mice , 2004, Acta orthopaedica Scandinavica.

[24]  R. Jain,et al.  Angiogenesis and growth of isografted bone: quantitative in vivo assay in nude mice. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[25]  P. Jiang,et al.  Monitoring of skeletal progression of prostate cancer by GFP imaging, X‐ray, and serum OPG and PTHrP , 2005, The Prostate.

[26]  I. Holen,et al.  Imaging the effects of castration on bone turnover and hormone‐independent prostate cancer colonization of bone , 2008, The Prostate.

[27]  J. Myers,et al.  Metastasis of squamous cell carcinoma of the oral tongue , 2007, Cancer and Metastasis Reviews.

[28]  E. Danen,et al.  BMP-7 inhibits TGF-β-induced invasion of breast cancer cells through inhibition of integrin β3 expression , 2011, Cellular Oncology.

[29]  R. Shah,et al.  In Vivo Visualization of Metastatic Prostate Cancer and Quantitation of Disease Progression in Immunocompromised Mice , 2003, Cancer biology & therapy.

[30]  T. Byzova,et al.  Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling. , 2007, Oncogene.

[31]  R. Nagle,et al.  Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. , 1994, Journal of cellular biochemistry. Supplement.

[32]  I. Holen,et al.  Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo , 2012, Clinical & Experimental Metastasis.

[33]  R. Vessella,et al.  Mechanisms, Hypotheses and Questions Regarding Prostate Cancer Micrometastases to Bone , 1998, Cancer and Metastasis Reviews.

[34]  G. van der Pluijm,et al.  Osteotropic cancers: from primary tumor to bone. , 2009, Cancer letters.

[35]  M. Horton,et al.  The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor , 1989, The Journal of cell biology.

[36]  C. Kao,et al.  Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines , 1998, International journal of cancer.

[37]  W. Jiang,et al.  Cell adhesion molecules and adhesion abnormalities in prostate cancer. , 2002, Critical reviews in oncology/hematology.

[38]  M. Reed,et al.  Macrophages promote angiogenesis in human breast tumour spheroids in vivo , 2005, British Journal of Cancer.

[39]  J. Feyen,et al.  Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. , 2011, Neoplasia.

[40]  K. Hillan,et al.  Neutralizing anti‐vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo , 1998, The Prostate.